AU2003240934A1 - Method for determining oligonucleotide concentration - Google Patents
Method for determining oligonucleotide concentrationInfo
- Publication number
- AU2003240934A1 AU2003240934A1 AU2003240934A AU2003240934A AU2003240934A1 AU 2003240934 A1 AU2003240934 A1 AU 2003240934A1 AU 2003240934 A AU2003240934 A AU 2003240934A AU 2003240934 A AU2003240934 A AU 2003240934A AU 2003240934 A1 AU2003240934 A1 AU 2003240934A1
- Authority
- AU
- Australia
- Prior art keywords
- oligonucleotide concentration
- determining oligonucleotide
- determining
- concentration
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38422202P | 2002-05-29 | 2002-05-29 | |
US60/384,222 | 2002-05-29 | ||
PCT/US2003/016874 WO2003102011A1 (en) | 2002-05-29 | 2003-05-29 | Method for determining oligonucleotide concentration |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003240934A1 true AU2003240934A1 (en) | 2003-12-19 |
Family
ID=29711995
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003240934A Abandoned AU2003240934A1 (en) | 2002-05-29 | 2003-05-29 | Method for determining oligonucleotide concentration |
Country Status (3)
Country | Link |
---|---|
US (1) | US20050153297A1 (en) |
AU (1) | AU2003240934A1 (en) |
WO (1) | WO2003102011A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
ATE413164T1 (en) * | 2000-11-09 | 2008-11-15 | Neopharm Inc | SN-38 LIPID COMPLEXES AND METHODS OF USE THEREOF |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
WO2003018018A2 (en) * | 2001-08-24 | 2003-03-06 | Neopharm, Inc. | Vinorelbine compositions and methods of use |
CA2466443A1 (en) * | 2001-11-09 | 2003-05-15 | Neopharm, Inc. | Selective treatment of il-13 expressing tumors |
US7138512B2 (en) * | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
AU2003296897A1 (en) * | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
AU2003268087A1 (en) * | 2002-08-23 | 2004-03-11 | Ian Ma | Liposomal gemcitabine compositions for better drug delivery |
KR20050105455A (en) * | 2003-02-11 | 2005-11-04 | 네오팜 인코포레이티드 | Manufacturing process for liposomal preparations |
WO2004087758A2 (en) * | 2003-03-26 | 2004-10-14 | Neopharm, Inc. | Il 13 receptor alpha 2 antibody and methods of use |
US20060165744A1 (en) * | 2003-05-22 | 2006-07-27 | Neopharm, Inc | Combination liposomal formulations |
US20060078560A1 (en) * | 2003-06-23 | 2006-04-13 | Neopharm, Inc. | Method of inducing apoptosis and inhibiting cardiolipin synthesis |
US10928366B2 (en) * | 2007-01-26 | 2021-02-23 | Sigma-Aldrich Co. Llc | Compositions and methods for combining protein precipitation and solid phase extraction |
US10434492B2 (en) * | 2007-01-26 | 2019-10-08 | Sigma-Aldrich Co. Llc | Compositions and methods for solid phase extraction of lipids |
JP2011523713A (en) * | 2008-06-05 | 2011-08-18 | バイオノボ・インコーポレーテッド | Method for quantification of various types of bioactive substances derived from plant compositions |
WO2020252292A1 (en) * | 2019-06-14 | 2020-12-17 | Laboratory Corporation Of America Holdings | Ion-pairing free lc-ms bioanalysis of oligonucleotides |
CN115960885B (en) * | 2022-10-09 | 2023-12-12 | 南京诺唯赞生物科技股份有限公司 | Method and composition for extracting nucleic acid from heparin sodium sample |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2547714B2 (en) * | 1981-10-23 | 1996-10-23 | モルキユラ− バイオシステムズ インコ−ポレテツド | Oligonucleotide therapeutic agent and method for producing the same |
US5064754A (en) * | 1984-12-14 | 1991-11-12 | Mills Randell L | Genomic sequencing method |
US5665710A (en) * | 1990-04-30 | 1997-09-09 | Georgetown University | Method of making liposomal oligodeoxynucleotide compositions |
PT706373E (en) * | 1992-03-23 | 2000-11-30 | Univ Georgetown | TAXOL ENCAPSULATED IN A LIPOSOM AND A METHOD |
JPH11511128A (en) * | 1995-08-01 | 1999-09-28 | ノバルティス・アクチエンゲゼルシャフト | Liposome oligonucleotide composition |
US5869242A (en) * | 1995-09-18 | 1999-02-09 | Myriad Genetics, Inc. | Mass spectrometry to assess DNA sequence polymorphisms |
US20030229040A1 (en) * | 1997-03-21 | 2003-12-11 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
US6559129B1 (en) * | 1997-03-21 | 2003-05-06 | Georgetown University | Cationic liposomal delivery system and therapeutic use thereof |
US6126965A (en) * | 1997-03-21 | 2000-10-03 | Georgetown University School Of Medicine | Liposomes containing oligonucleotides |
US7262173B2 (en) * | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
US6063809A (en) * | 1997-08-26 | 2000-05-16 | Bioavailability Systems, Llc | Anti-first-pass effect compounds |
US6146659A (en) * | 1998-07-01 | 2000-11-14 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6461637B1 (en) * | 2000-09-01 | 2002-10-08 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
US6416975B1 (en) * | 1998-11-12 | 2002-07-09 | Gliatech, Inc. | Human glycine transporter type 2 |
BR0114713A (en) * | 2000-10-16 | 2004-01-13 | Neopharm Inc | Liposomal formulation of mitoxantrone |
ATE413164T1 (en) * | 2000-11-09 | 2008-11-15 | Neopharm Inc | SN-38 LIPID COMPLEXES AND METHODS OF USE THEREOF |
WO2002059337A1 (en) * | 2001-01-26 | 2002-08-01 | Georgetown University School Of Medicine | Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof |
WO2002081641A2 (en) * | 2001-04-06 | 2002-10-17 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
AU2002303261A1 (en) * | 2001-04-06 | 2002-10-21 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
WO2002081642A2 (en) * | 2001-04-06 | 2002-10-17 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
CA2466443A1 (en) * | 2001-11-09 | 2003-05-15 | Neopharm, Inc. | Selective treatment of il-13 expressing tumors |
US7244565B2 (en) * | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
US7138512B2 (en) * | 2002-04-10 | 2006-11-21 | Georgetown University | Gene SHINC-2 and diagnostic and therapeutic uses thereof |
US20050148528A1 (en) * | 2002-05-20 | 2005-07-07 | Neopharm, Inc | Method for reducing platelet count |
US20030228317A1 (en) * | 2002-05-22 | 2003-12-11 | Prafulla Gokhale | Gene BRCC-1 and diagnostic and therapeutic uses thereof |
EA200401565A1 (en) * | 2002-05-24 | 2005-04-28 | Неофарм, Инк. | METHOD FOR OBTAINING CARDIOLYPINE OR ANALOGUE OF CARDIOLIPINE (OPTIONS), METHOD FOR OBTAINING LIPOSOME AND COMPOSITION OF CARDIOLIPINE FOR TREATING DISEASES (OPTIONS) |
WO2003099830A2 (en) * | 2002-05-24 | 2003-12-04 | Neopharm, Inc. | Cardiolipin compositions, methods of preparation and use |
AU2003296897A1 (en) * | 2002-08-20 | 2004-05-04 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
AU2003268087A1 (en) * | 2002-08-23 | 2004-03-11 | Ian Ma | Liposomal gemcitabine compositions for better drug delivery |
US20050277611A1 (en) * | 2002-10-16 | 2005-12-15 | Neopharm, Inc. | Cationic cardiolipin analoges and its use thereof |
-
2003
- 2003-05-29 AU AU2003240934A patent/AU2003240934A1/en not_active Abandoned
- 2003-05-29 US US10/515,788 patent/US20050153297A1/en not_active Abandoned
- 2003-05-29 WO PCT/US2003/016874 patent/WO2003102011A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US20050153297A1 (en) | 2005-07-14 |
WO2003102011A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002367180A1 (en) | Concentration measuring method | |
AU2002353108A1 (en) | Method for determining location information | |
AUPS298102A0 (en) | Method for performing chemical reactions | |
AU2003240934A1 (en) | Method for determining oligonucleotide concentration | |
AU2002312859A1 (en) | Method for determining gene expression | |
IL152746A0 (en) | Biosensor for molecules | |
EP1496354A4 (en) | Substrate determining method | |
AU2003900285A0 (en) | Electrochemical detection method | |
AU2003272890A1 (en) | Static analysis method for lyee-oriented software | |
AU2003902613A0 (en) | Self-surveying method | |
AU2003250080A1 (en) | Oligonucleotides for detecting micro-organisms | |
AU2003240558A1 (en) | Biological results evaluation method | |
AU2003303869A1 (en) | Methods for nucleic acid analysis | |
AU2003901196A0 (en) | Analysis method | |
AU2003275856A1 (en) | Method for detecting halitosis | |
AU2003255104A1 (en) | Method for comparing gene expression level | |
AU2003248589A1 (en) | Method for determining free thrombin concentration | |
AU2003233330A1 (en) | Method for quantifying molecules | |
AU2003284369A1 (en) | Method for detecting nucleic acids | |
AU2003302685A1 (en) | Methylation dna detecting method | |
AU2003253009A1 (en) | Method and apparatus for determining ischaemia | |
PL376503A1 (en) | Assay method | |
AU2003253813A1 (en) | Method for colpoplasty | |
EP1701920A4 (en) | Method for treating-containing solutions | |
AU2003215086A1 (en) | Method for detecting polymorphisms in nucleic acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |